Tumors with poorly defined transition areas between healthy skin and tumor cells, corresponding by extrapolation to the field cancerization of squamous cell carcinoma/actinic keratoses, often require specific immunohistochemistry studies (S-100, Sox-100, PRAME) in melanoma [41] and cytokeratin 7 in EMPD [42]. The gene discussed is KRT7; the disease is melanoma.